Novel arginine, glycine, aspartic acid derivatives as platelet-a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 19, 530330, 530331, 548953, A61K 3700

Patent

active

050533924

ABSTRACT:
Disclosed are novel amino acid derivatives of the formula: ##STR1## wherein X is H, amidino or ##STR2## Y is H, amino or ##STR3## Z is ##STR4## OR.sub.1 or a naturally occurring L-amino acid, bounded to the carbon atom at the .alpha.-amino position;

REFERENCES:
patent: 4683291 (1987-07-01), Zimmerman et al.
Chou et al., "Prediction of Protein Conformation", Biochemistry, vol. 13, No. 2 (1974), pp. 222-224.
Pierschbacher et al., "Influence of Sterochemistry of the Sequence", J. Biol. Chem., vol. 262, No. 86, pp. 17294-17298 (1987).
Ginsberg et al.; "Inhibition of Fibronectin Binding to Platelets by Proteolytic Fragments and Synthetic Peptides Which Support Fibroblast Adhesion"; The Journal of Biological Chemistry, vol. 260, No. 7, Apr. 10, 1985; pp. 3931-3936.
Gartner et al.; "The Tetrapeptide Analogue of the Cell Attachment Site of Fibronectin Inhibits Platelet Aggregation and Fibrinogen Binding to Activated Platelets", The Journal of Biological Chemistry; vol. 260, No. 22, Oct. 5, 1985; pp. 11891-11894.
Haverstick et al., "Inhibition of Platelet Adhesion to Fibronectin, Fibrinogen, and vWF Substrates by a Synthetic Tetrapeptide Derived From the Cell-Binding Domain of Fibronectin"; Blood, vol. 66, No. 4 (Oct.), 1985: pp. 946-952.
Plow et al., "Inhibition of Fibrinogen Binding to Human Platelets by the Tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline"; Proc. Natl. Acad. Sci. U.S.A., vol. 79, pp. 3711-3715, Jun. 1982.
Plow et al., "The Effect of Arg-Gly-Asp-Containing Peptides on Fibrinogen and von Willebrand Factor Binding to Platelets"; Proc. Natl. Acad. Sci. U.S.A., vol. 82, pp. 8057-8061, Dec. 1985.
Santoro et al. ; "Competition for Related but Nonidentical Binding Sites on the Glycoprotein IIb-IIIa Complex by Peptides Derived from Platelet Adhesive Proteins"; Cell, vol. 48, 867-873, Mar. 13, 1987.
Ruggeri et al.; "Inhibition of Platelet Function with Synthetic Peptides Designed to be High-Affinity Antagonists of Fibrinogen Binding to Platelets"; Proc. Natl. Acad. Sci. U.S.A.; vol. 83, pp. 5708-5712, Aug. 1986.
Ruoslahti et al. ; "Arg-Gly-Asp: A Versatile Cell Recognition Signal", Cell, vol. 44, 517-518, Feb. 28, 1986.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel arginine, glycine, aspartic acid derivatives as platelet-a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel arginine, glycine, aspartic acid derivatives as platelet-a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel arginine, glycine, aspartic acid derivatives as platelet-a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1755071

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.